
==== Front
Arch Virol
Arch. Virol
Archives of Virology
0304-8608 1432-8798 Springer-Verlag Vienna 

6271096
BF01315263
10.1007/BF01315263
Original Papers
Antigenicity of mouse hepatitis virus strain 3 subcomponents in C57 strain mice
Hasony H. J.  Macnaughton M. R.  grid.415052.7000000040606323XDivision of Communicable Diseases, Clinical Research Centre, Harrow, Middlesex England 
1981 
69 1 33 41
10 2 1981 13 4 1981 © Springer-Verlag 1981This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Summary
C57 strain mice were inoculated intraperitoneally with denatured mouse hepatitis virus strain 3 particles and virus surface projection, membrane and ribonucleoprotein subcomponents, obtained from detergent treated purified virus preparations. All immunised animals developed high levels of serum antibody directed against the respective antigens, detectable by enzyme-linked immunosorbent assay. Mice that had been immunised with denatured virus particles or surface projections were protected against infection with mouse hepatitis virus strain 3, whereas immunisation with virus membrane or ribonucleoprotein subcomponents failed to protect mice against virus challenge.

Keywords
HepatitisInfectious DiseaseImmunosorbent AssayVirus ParticleSerum Antibodyissue-copyright-statement© Springer-Verlag 1981
==== Body
With 2 Figures
==== Refs
References
1. Anderson R.  Cheley S.  Haworth-Hatherell E.   Comparison of polypeptides of two strains of murine hepatitis virus Virology 1979 97 492 494 224595 
2. Bond C. W.  Leibowitz J. L.  Robb J. A.   Pathogenic murine coronaviruses. 11. Characterization of virus-specific proteins of murine coronaviruses JHMV and A 59V Virology 1979 94 371 384 572113 
3. Cartwright B.  Smale C. J.  Brown F.   Surface structure of vesicular stomatitis virus J. gen. Virol. 1969 5 1 10 4309923 
4. Collins M. S.  Alexander D. J.   The polypeptide composition of isolated surface projections of avian infectious bronchitis virus J. gen. Virol. 1980 48 213 217 6247435 
5. Garwes D. J.  Lucas M. H.  Higgins D. A.  Pike B. V.  Cartwright S. F.   Antigenicity of structural components from porcine transmissible gastroenteritis virus Vet. Microbiol. 1978 3 179 190 
6. Garwes D. J.  Pocock D. H.  Pike B. V.   Isolation of subviral components from transmissible gastroenteritis virus J. gen. Virol. 1976 32 283 294 190341 
7. Greenwood F. C.  Hunter W. M.  Glover J. S.   The preparation of131 I-labelled human growth hormone of high specific radioactivity Biochem. J. 1963 89 114 123 14097352 
8. Hunsmann G.  Moennig V.  Schafer W.   Properties of mouse leukemia viruses. IX Active and passive immunization of mice against friend leukemia with isolated viral GP71  glycoprotein and its corresponding antiserum Virology 1975 66 327 329 1136142 
9. Kraaijeveld C. A.  Madge M. H.  Macnaughton M. R.   Enzyme-linked immunosorbent assay for coronaviruses HCV 229E and MHV3 J. gen. Virol. 1980 49 83 89 6252292 
10. Kraaijeveld C. A.  Reed S. E.  Macnaughton M. R.   Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus 229E group viruses J. clin. Microbiol. 1980 12 493 497 6252244 
11. le Prevost C.  Levy-Leblond E.  Virelizier J-L.  Dupuy J. M.   Immunopathology of mouse hepatitis virus type 3 infection. 1. Role of humoral and cellmediated immunity in resistance mechanisms J. Immunol. 1975 114 221 225 163277 
12. Macnaughton M. R.   The polypeptides of human and mouse coronaviruses Arch. Virol. 1980 63 75 80 6245634 
13. Macnaughton M. R.  Davies H. A.  Nermut M. V.   Ribonucleoprotein-like structures from coronavirus particles J. gen. Virol. 1978 39 545 549 207820 
14. Macnaughton M. R.  Hasony H. J.  Madge M. H.  Reed S. E.   Antibody to virus components in volunteers experimentally infected with HCV229E group viruses Infect. Immun. 1981 31 845 849 6262250 
15. Macnaughton M. R.  Madge M. H.   The polypeptide composition of avian infectious bronchitis virus particles Arch. Virol. 1977 55 47 54 200202 
16. Macnaughton M. R.  Patterson S.   Mouse hepatitis virus strain 3 infection of C57, A/Sn and A/J strain mice and their macrophages Arch. Virol. 1980 66 71 75 6254475 
17. McIntosh K.   Coronaviruses: a comparative review Curr. Top. Microbiol. Immunol. 1974 63 85 129 
18. Pocock D. H.  Garwes D. J.   The polypeptides of haemagglutinating encephalomyelitis virus and isolated subviral particles J. gen. Virol. 1977 37 487 499 
19. Schmidt O. W.  Kenny G. E.   Correlation of specific antigens with structural proteins in coronaviruses 229E and OC43 Fed. Proc. 1979 38 910 
20. Skinner G. R. B.  Williams D. R.  Buchan A.  Whitney J.  Harding M.  Bodfish K.   Preparation and efficacy of an inactivated subunit vaccine (NFU, BHK) against type 2 herpes simplex virus infection Med. Microbiol. Immunol. 1978 166 119 132 214676 
21. Sturman L. S.   Characterization of a coronavirus. 1. Structural proteins: effects of preparative conditions on the migration of protein in polyacrylamide gels Virology 1977 77 637 649 855186 
22. Sturman L. S.  Holmes K. V.  Behnke J.   Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid J. Virol. 1980 33 449 462 6245243 
23. Tyrrell D. A. J.  Alexander D. J.  Almeida J. D.  Cunningham C. H.  Easterday B. C.  Garwes D. J.  Hierholzer J. C.  Kapikian A.  Macnaughton M. R.  McIntosh K.   Coronaviridae: second report Intervirology 1978 10 321 328 213397 
24. Webster R. G.  Laver W. G.   Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether—and detergent—disrupted virus J. Immunol. 1966 96 596 605 5936287 
25. Wege H.  Wege H.  Nagashima K.  ter Meulen V.   Structural polypeptides of the murine coronavirus JHM J. gen. Virol. 1979 42 37 47 759559 
26. Virelizier J.-L.  Allison A. C.   Correlation of persistent mouse hepatitis virus (MHV3) infection with its effect on mouse macrophage cultures Arch. Virol. 1976 50 279 285 179499

